Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $6.10, $0.15 better than the analyst estimate of $5.95. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $11.29 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.